SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NNVC - NanoViricides, Inc. -- Ignore unavailable to you. Want to Upgrade?


To: RoadyHD who wrote (12785)5/27/2020 10:19:11 AM
From: Savant  Respond to of 12873
 
The financial obstacle would be the greedy someone, grabbing as much as he can, from the 'general business' use of the funds...count on it.



To: RoadyHD who wrote (12785)5/27/2020 11:55:44 AM
From: old 'n cranky  Respond to of 12873
 
You make it sound juicy enough...reasonable and logical....but when you get to the end, the Let's see part, I'm reminded of the quote that has been questionably attributed to Einstein but never really nailed down as to its source:
the definition of insanity is doing the same thing over and over and expecting a different result.
No matter who said it, it makes sense.
And "we've got our candidate ligand" a whole bunch of times, haven't we?

Good luck.



To: RoadyHD who wrote (12785)5/27/2020 5:29:51 PM
From: HardToFind  Respond to of 12873
 
I'd love to see the drug succeed. It would be great for Covid-19 patients, but I suspect not so great for NNVC shareholders. I'd love to be wrong, but I'll be watching NNVC's progress from the sidelines.

I'm more inclined to put my speculative money into the junior gold miners index (GDXJ) about now...better risk profile IMO.